Survey on vaccine data looks to improve ways pharmacy can share information

Survey on vaccine data looks to improve ways pharmacy can share information

May 17 2018 The Professional Record Standards Body (PRSB) is inviting views on information...

Psoriasis Assocation launches WhatsApp service

Psoriasis Assocation launches WhatsApp service

May 15 2018 A new support service for people with psoriasis has been launched by Psoriasis...

NHS to introduce new measures to help monitor medication errors

NHS to introduce new measures to help monitor medication errors

May 15 2018 The NHS is to introduce a series of new indicators to show whether a prescription may...

ICO consults on how it should use its increased regulatory powers with GDPR

ICO consults on how it should use its increased regulatory powers with GDPR

May 11 2018 The Information Commissioner’s Office is asking for views on the way it intends...

RCGP offers advice for around online consultations safety

RCGP offers advice for around online consultations safety

April 11 2018 Advice and considerations around the safety of online patient consultations has...

  • Survey on vaccine data looks to improve ways pharmacy can share information

    Survey on vaccine data looks to improve ways pharmacy can share information

    Thursday, 17 May 2018 15:26
  • Psoriasis Assocation launches WhatsApp service

    Psoriasis Assocation launches WhatsApp service

    Tuesday, 15 May 2018 12:10
  • NHS to introduce new measures to help monitor medication errors

    NHS to introduce new measures to help monitor medication errors

    Tuesday, 15 May 2018 11:58
  • ICO consults on how it should use its increased regulatory powers with GDPR

    ICO consults on how it should use its increased regulatory powers with GDPR

    Friday, 11 May 2018 11:38
  • RCGP offers advice for around online consultations safety

    RCGP offers advice for around online consultations safety

    Wednesday, 11 April 2018 13:19

a man taking medication imageFebruary 2 2018

Details of the review into prescribed medicines that may cause dependence or withdrawal have been set out.


Public Health Minister Steve Brine has commissioned Public Health England to review the evidence and report back in early 2019. It has been asked to look at:

  • prevalence and prescribing patterns;
  • the nature and likely causes of dependence or discontinuation syndrome among some people who take these medicines;
  • effective prevention and treatment of dependence and discontinuation syndrome for each drug category.

Drug classes specifically targeted will be benzodiazepines, Z-drugs, GABA-ergic medicines, opioid pain medications, antidepressants, as well as those that are prescribed to treat anxiety, insomnia, chronic non-cancer pain and depression. The review will look at the use of the medicines by adults, and community prescribing.

Not included in the review’s remit are:

  • cancer and terminal pain;
  • over-the-counter medicines;
  • prescribing in hospitals and prisons;
  • other medicines, such as anti-psychotics, stimulants, ‘smart drugs’, or anti-obesity drugs.

PHE will use a number of methods to gather evidence, including “analysing all prescription and some GP patient data to understand prevalence and detail of prescribing patterns, patients and conditions.”

Link:
PHE announcement      

Management News

May 22 2018 ‘Scratch Beneath the Surface’, a new UK public health initiative intended to improve people’s understanding of atopic dermatitis, has been launched online.
May 18 2018 New guidance to support the integration of community pharmacy services into primary care homes (PCHs) has been published.  The National Association of Primary Care’s report looks at ways...